The Use of Biometric Feedback Devices for Stratification of Deep Brain Stimulation (DBS) Eligibility and Treatment Response in Parkinson Disease
Objective: To review the literature on digital biomarkers’ role in DBS candidacy assessment and treatment response in people with Parkinson Disease (PwP). Background: Visit frequency…Orthostatic Hypotension：a Clinical Marker for the Body-First Subtype of Patients with Parkinson’s Disease
Objective: Our study aimed to investigate the clinical characteristics of PD patients stratified by OH status before and after levodopa challenge to explore the hypothesis…Assessment of pain in people with Parkinson’s disease: an exploratory survey of international nursing experiences
Objective: To explore the methods and tools used by PDNS to assess pain, as well as the main indicators, barriers and difficulties in its evaluation.…Nonmotor symptoms in Spinocerebellar ataxia type 12 (SCA 12)
Objective: To find the frequency and extent of depression, autonomic disturbances, and cognitive impairment in patients with SCA12 and exploring its association with motor symptoms…Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)
Objective: To validate the self-completed version of the International Movement Disorder Society – Non-Motor Rating Scale (MDS-NMS)1, named the MDS-NMS – Questionnaire (MDS-NMS-Q). Background: The…Gender Disparities in Depressive Symptoms among Hispanic Parkinson’s Disease Patients: A Cross-Sectional Study
Objective: Investigate gender-specific disparities in depressive symptoms among Hispanic Parkinson's disease (PD) patients using Center for Epidemiologic Studies Depression Scale (CES-D) scores. Background: PD not…A Comprehensive Evaluation of the Non-Motor Symptoms, Quality of Life and Caregiver Burden in Patients with Idiopathic Dystonia
Objective: To study various non-motor symptoms in idiopathic dystonia patients using validated scales. Background: Dystonia is a hyperkinetic movement disorder. There has been a recent…Prospective and Controlled Glucocerebrosidase-related Parkinson’s Disease Evaluation of Non-Motor Symptoms (PROGENS-PD)
Objective: To outline the protocol for an upcoming study aimed at describing the non-motor symptoms (NMS) in Parkinson’s disease (PD) patients with heterozygous glucocerebrosidase (GBA)…Dopamine agonist use and psychotic symptoms in patients with Parkinson’s disease.
Objective: To describe the clinical and demographic characteristics of patients with PDP and their relationship with the use of DAs. Background: Parkinson’s Disease Psychosis (PDP)…Nocturnal Blood Pressure, Non-Dipping, Psychosis And Non-Motor Symptoms In Early Stages Of Huntington’s Disease Patients
Objective: The aim of this study was to determine the relationship between 24 h ambulatory blood pressure measurements (ABPM), i.e., absence or presence of nocturnal…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 55
- Next Page »